General Information of Drug Transporter (DT)
DT ID DTD0128 Transporter Info
Gene Name SLC19A3
Transporter Name Thiamine transporter 2
Gene ID
80704
UniProt ID
Q9BZV2
Post-Translational Modification of This DT
Overview of SLC19A3 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A3 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

45

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC19A3 Asparagine 45 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A3 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

166

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC19A3 Asparagine 166 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        11 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A3 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

210

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 210 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A3 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

211

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 211 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC19A3 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

212

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 212 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC19A3 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

235

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 235 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC19A3 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

239

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 239 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC19A3 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

241

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 241 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC19A3 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

472

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 472 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC19A3 [7] , [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

476

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 476 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC19A3 [8] , [10]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

482

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 482 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC19A3 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

488

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 488 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC19A3 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

493

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Serine 493 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC19A3 [13] , [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

220

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Threonine 220 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC19A3 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

234

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Threonine 234 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC19A3 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

240

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Threonine 240 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC19A3 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

494

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC19A3 Threonine 494 has the potential to affect its expression or activity.
References
1 Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S19A3_HUMAN)
3 Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
4 Integrated Proteomics Reveals Apoptosis-related Mechanisms Associated with Placental Malaria. Mol Cell Proteomics. 2019 Feb;18(2):182-199.
5 Phosphoproteomic analysis identifies the tumor suppressor PDCD4 as a RSK substrate negatively regulated by 14-3-3. Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):E2918-27.
6 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
7 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
8 Super-SILAC mix coupled with SIM/AIMS assays for targeted verification of phosphopeptides discovered in a large-scale phosphoproteome analysis of hepatocellular carcinoma. J Proteomics. 2017 Mar 22;157:40-51.
9 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
10 Feasibility of label-free phosphoproteomics and application to base-line signaling of colorectal cancer cell lines. J Proteomics. 2015 Sep 8;127(Pt B):247-58.
11 Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
12 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
13 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
14 Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.